PO Box 8266
Angelo St
South Perth
Western Australia 6151
 
Tel
Fax
Email
:
:
:
61 8 9224 2446
61 8 9450 8553
info@asainc.net.au
Welcome!

Welcome to the web site of the Australian Society for Antimicrobials.

 

Since becoming an Incorporated Society in March 1999, ASA membership now covers a diverse background of professions interested in the study of antimicrobials including clinical microbiologists and infectious diseases physicians, respiratory and ICU physicians, medical and non-medical microbiologists and scientists, pharmacists, veterinarians, undergraduate and postgraduate students, and industry representatives from pharmaceutical and diagnostic/research biomedical companies.

 

Although ASA's membership is primarily based in Australia and New Zealand, it now extends to Asia, North America, Europe and the United Kingdom.

 

On this site you can access the Society's Objectives and Constitution and the Committee Members. In addition the Society's Membership Subscription Form and details of the Annual Scientific Meeting can be downloaded.

 

Members of the Society may wish to download the current and previous newsletters as well as abstracts from previous annual scientific meetings in the Members Area.

 

There are also links to many other areas and related societies.

 

If you would like to contact the Society please email info@asainc.net.au.

 


Current Newsletter:

(You must be logged in to view this newsletter.)

  • Australian New Zealand Cooperative on Outcomes in Staphylococcal Sepsis (ANZCOSS) Study
  • ASA 2010 Foundation Members
  • Australian Society for Antimicrobials 11th Annual Scientific Meeting (Antimicrobials 2010)
  • Newsletter Contributions
  • Emerging Treatment Options for Hepatitis C Virus
  • Highlights from the 49th ICAAC
  • Meeting Calendar
  • What's Happening in Susceptibility Testing
  • Picture Quiz

What's New

More news on the ASA News page.

8-Mar-2010

2010 bioMerieux ASA Identifying Resistance Travel Award

The Australian Society for Antimicrobials (ASA) congratulates Dr Paul Ingram for being awarded the 2010 bioMerieux ASA Identifying Resistance Travel Award for his "Antimicrobial 2010" presentation "Detection of AmpC Beta-lactamases Using a Novel Etest Strip"

This Award is presented to an ASA Member on the basis of a proffered paper (oral or poster) presented during the ASA's Annual Scientific Meeting dealing with the identification of antimicrobial resistance in a routine clinical setting.

The Award consists of AU$1000 cash prize, a commemorative plaque, and the provisions of flights, accommodation and registration for the recipient to attend "Antimicrobials 2011" in Melbourne (Thursday 24th to Saturday 26th February 2011)

The ASA Executive thanks Noel Wentworth and bioMerieux for once again providing this award.

A copy of Paul's poster and many of the other "Antimicrobials 2010" presentations will be available shortly in the Members' Area of the ASA website (www.asainc.net.au)


7-Mar-2010

ASA AstraZeneca Travel Award

ICAAC
Boston, United States of America
12 - 15 September 2010
Online Abstract Submission closes 7 May 2010
Website: http://www.icaac.org

This award is for attendance at the 50th Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC) in Boston (12 - 15 September 2010). The award consists of return economy airfare, accommodation and conference registration up to the value of AUD5,000.

Applicants must have current ASA membership and must have been an ASA member for at least the last 12 months. The Award is conditional upon the abstract being accepted by the ICAAC program committee for presentation (oral or poster). In addition the recipient of the Award is required to write a report on the meeting for the ASA Newsletter.

ASA members who wish to apply for this award are invited to submit their application to the ASA Secretary Despina Kotsanas at info@asainc.net.au. before Friday 7 May 2010. The application should include a copy of the ICAAC abstract and for abstracts with more than one author, a letter stating the relative contribution of the applicant towards the research.

The Australain Society of Antimicrobials once again thanks AstraZeneca Australia for providing this award.


20-Feb-2010

ASA 2010 Foundation (Sustaining) Members

The Australian Society for Antimicrobials wishes to acknowledge the following companies for becoming Foundation (Sustaining) Members of the Society

Janssen-Cilag
Novartis
GlaxoSmithKline
AstraZeneca
Bayer Australia
Becton Dickinson
bioMerieux Australia
Immuno
Merck Sharp and Dohme
Pfizer Australia
ThermoFisher Scientific Products (Oxoid Australia)

Foundation Members websites can be located in the Foundation (Sustaining) Members section of the ASA webpage


5-Jan-2010

Australian New Zealand Cooperative on Outcomes in Staphylococcal Sepsis (ANZCOSS) Study

Staphylococcal sepsis remains a significant healthcare problem worldwide, both in the community and in hospital practice. The literature demonstrates that outcomes are suboptimal for some cases of invasive staphylococcal infection. Factors known to impact on outcomes include resistance, especially methicillin resistance, and toxin production such as TSST-1 and PVL.

To understand the local epidemiology of severe Staphylococcus aureus disease in Australia and New Zealand a cooperative, under the auspices of the Australian Society for Antimicrobials, has been established; the Australian New Zealand Cooperative on Outcomes in Staphylococcal Sepsis (ANZCOSS).


4-Jan-2010

Antimicrobials 2010 ASA Travel Award Recipients

The Australian Society for Antimicrobials Committee congratulate the following ASA Members for being awarded an ASA Travel Award to attend Antimicrobials 2010 in Sydney (25 - 27 February 2010):

Stephen Tristram. University of Tasmania, Australia.
Screening and Identifying BLNAR and BLPACR Strains of H. influenzae.

Natasha Holmes. Austin Health, Australia.
Vancomycin Minimum Inhibitory Concentration (MIC) in Australian Staphylococcus aureus Bactaeraemia (SAB) - An Australian and New Zealand Cooperative on Outcomes in Staphylococcal Sepsis (ANZCOSS) Substudy.

Steven Tong. Menzies School of Health Research, Australia.
Molecular Detection of the H275Y Oseltamivir Resistance Mutation in Influenza A/H1N1 2009 by Step-Down RT-PCR and SYBR Green High-Resolution Melting Analysis.


6-Apr-2009

ASA ISSSI2010 Travel Scholarship: Advanced Warning

The next International Symposium on Staphylococci and Staphylococcal Infections (ISSSI) will be held in Bath in the United Kingdom in September 2010.

The website www.isssi2010.com will be made live in June 2009.

ASA will be providing a travel scholarship preferably to a PhD student or an advanced trainee who will be presenting at the meeting.

The scholarship consists of return economy airfare, accommodation and conference registration up to the value of AU$5,000.

Applicants must have current ASA membership and must have been a member for at least the last 12 months. The scholarship is restricted to Australian and New Zealand ASA financial members and is conditional upon the abstract being accepted by the ISSSI2010 program committee for presentation (oral or poster). In addition the recipient of the scholarship is required to write a report on the meeting for the ASA Newsletter .

Eligible ASA members who wish to apply for this scholarship are invited to submit their application to the ASA Secretary Despina Kotsanas at info@asainc.net.au. The application should include a copy of their abstract and for abstracts with more than one author, a letter stating the relative contribution of the applicant towards the research.